No Data
No Data
Wai Chun Biotechnology (00660) appoints Lam Kai-ki as company secretary and authorized representative
Zhitong Finance App News, Wei Jun Biotechnology (00660) announced that Li Huifang has resigned as the company's company secretary and no longer serves as the company's authorized representative. Lin Qiji has been appointed as the company's secretary and authorized representative, effective March 28, 2024.
WAI CHUN BIOTEC: Interim Report 2023/24
Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows
Wai Chun Bio-Technology's (HKG:0660) attributable loss narrowed to HK$6.7 million, or HK$0.0393 per share, in the half-year ended Dec. 31, 2023, from HK$7.8 million, or HK$0.0457 per share, in the yea
Weijun Biotechnology (00660) announced interim results. Shareholders' share loss of HK$6.734 million narrowed 14.01% year-on-year
According to the Zhitong Finance App, Weijun Biotechnology (00660) announced results for the six months ended December 31, 2023. The group achieved revenue of HK$190 million during the period, a year-on-year decrease of 53.01%; the loss due to company owners during the period was HK$6.734 million, a year-on-year decrease of 14.01%; the basic loss per share was HK$3.93. According to the announcement, the decline in revenue was due to a decrease in market consumption and demand during the period.
WAI CHUN BIOTEC: INTERIM RESULTS FOR THE SIX MONTHSENDED 31 DECEMBER 2023
Weijun Biotechnology (00660.HK) will hold a board meeting on February 29 to approve the interim results
Gelonghui, Feb. 19 | Weijun Biotechnology (00660.HK) announced that the company will hold a board meeting on February 29, 2024 to consider and approve the unaudited interim results announcement and release of the company and its subsidiaries for the six months ended December 31, 2023.
No Data